Literature DB >> 10951462

Malignant peripheral nerve sheath tumors in neurofibromatosis 1.

A A King1, M R Debaun, V M Riccardi, D H Gutmann.   

Abstract

One of the most clinically aggressive cancers associated with neurofibromatosis 1 (NF1) is the malignant peripheral nerve sheath tumor (MPNST). To determine the incidence and relative risk (RR) of MPNSTs in individuals with NF1, 1,475 individuals with NF1 were included from a cohort of patients examined by a single experienced geneticist from 1977 to 1996. The end points were incidence of MPNST, relative risk of MPNST, and relative risk associated with specific NF1 physical findings. Thirty-four individuals were identified with MPNST (2%). The relative risk of MPNST was higher than expected with an RR value of 113 (95% confidence interval [CI] = 78-158). The average 10-year annual incidence of MPNST between the second and fifth decade of life was roughly the same with a range of 0.0013 and 0.0068 MPNST per patient year. Most lesions occurred in the limbs (n = 18; 53%), and those with limb lesions survived longer than those with nonlimb MPNSTs. Pain associated with a mass was the greatest risk factor associated with MPNST development (RR = 31.4; 95% CI = 13.2-75.1). Further biological and epidemiological studies are needed to determine other factors that influence the risk of MPNST development in individuals affected with NF1. Am. J. Med. Genet. 93:388-392, 2000. Published 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10951462

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  46 in total

1.  Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.

Authors:  Christian Hagel; Ulrich Zils; Matthias Peiper; Lan Kluwe; Stefan Gotthard; Reinhard E Friedrich; David Zurakowski; Andreas von Deimling; Victor Felix Mautner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

2.  Acute monocular blindness resulting from transformation of von Recklinghausen's neurofibromatosis to malignant melanocytic schwannomas.

Authors:  Stephen H Wrzesinski; Konstantin H Dragnev; Lorna K Mayo; Brent T Harris; Jonathan D Marotti
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

3.  The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.

Authors:  Christine S Higham; Eva Dombi; Aljosja Rogiers; Sucharita Bhaumik; Steven Pans; Steve E J Connor; Markku Miettinen; Raf Sciot; Roberto Tirabosco; Hilde Brems; Andrea Baldwin; Eric Legius; Brigitte C Widemann; Rosalie E Ferner
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

4.  Role of ultrasonography in detection of renal artery pseudoaneurysm caused by retroperitoneal malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1.

Authors:  Abhishek Jha; Prakhar Gupta; Shagufta Wahab; Gagan Gupta; Syed YasribNahid Zaidi
Journal:  J Med Ultrason (2001)       Date:  2013-06-11       Impact factor: 1.314

Review 5.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

6.  Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.

Authors:  Emre Cecen; Dilek Ince; Kamer Mutafoglu Uysal; Erdener Ozer; Riza Cetingoz; Ali Aykan Ozguven; Handan Cakmakci; Faik Sarialioglu; Nur Olgun
Journal:  Childs Nerv Syst       Date:  2011-03-26       Impact factor: 1.475

7.  Malignant peripheral nerve sheath tumor of proximal third tibia.

Authors:  Arunkumar Rao; Sachin B Ingle; Pawan Rajurkar; Vishav Goyal; Nikhil Dokrimare
Journal:  World J Clin Oncol       Date:  2015-10-10

Review 8.  Imaging of Abdominal Wall Masses, Masslike Lesions, and Diffuse Processes.

Authors:  David H Ballard; Parisa Mazaheri; Daniel C Oppenheimer; Meghan G Lubner; Christine O Menias; Perry J Pickhardt; William D Middleton; Vincent M Mellnick
Journal:  Radiographics       Date:  2020-04-24       Impact factor: 5.333

9.  Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.

Authors:  Jordi Barretina; Barry S Taylor; Shantanu Banerji; Alexis H Ramos; Mariana Lagos-Quintana; Penelope L Decarolis; Kinjal Shah; Nicholas D Socci; Barbara A Weir; Alan Ho; Derek Y Chiang; Boris Reva; Craig H Mermel; Gad Getz; Yevgenyi Antipin; Rameen Beroukhim; John E Major; Charles Hatton; Richard Nicoletti; Megan Hanna; Ted Sharpe; Tim J Fennell; Kristian Cibulskis; Robert C Onofrio; Tsuyoshi Saito; Neerav Shukla; Christopher Lau; Sven Nelander; Serena J Silver; Carrie Sougnez; Agnes Viale; Wendy Winckler; Robert G Maki; Levi A Garraway; Alex Lash; Heidi Greulich; David E Root; William R Sellers; Gary K Schwartz; Cristina R Antonescu; Eric S Lander; Harold E Varmus; Marc Ladanyi; Chris Sander; Matthew Meyerson; Samuel Singer
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

10.  Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma.

Authors:  V F Mautner; R E Friedrich; A von Deimling; C Hagel; B Korf; M T Knöfel; R Wenzel; C Fünsterer
Journal:  Neuroradiology       Date:  2003-07-24       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.